Melatonin in sleep disorders and jet-lag

Neuroendocrinology Letters

Volumn 23, Issue SUPPL. 1, 2002, Pages 9-13

  Cardinali, Daniel P ^a   Brusco, Luis I ^a   Pérez Lloret, Santiago ^a   Furio, Analía M ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Aging; Benzodiazepines; Jet lag; Melatonin; Sleep disorders

Indexed keywords

BENZODIAZEPINE; BENZODIAZEPINE DERIVATIVE; MELATONIN; MELATONIN DERIVATIVE; TEMAZEPAM;

AGED; AGING; ALZHEIMER DISEASE; BODY TEMPERATURE; CHRONIC DISEASE; CIRCADIAN RHYTHM; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG ABSORPTION; DRUG ACTIVITY; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG DIFFUSION; DRUG EFFECT; DRUG EFFICACY; DRUG ELIMINATION; DRUG EXCRETION; DRUG HALF LIFE; DRUG MECHANISM; DRUG METABOLISM; DRUG PROTEIN BINDING; DRUG RELEASE; DRUG USE; HUMAN; INSOMNIA; ISCHEMIC HEART DISEASE; JET LAG; NONHUMAN; REVIEW; SLEEP DISORDER; SLEEP WAKING CYCLE; TRANQUILIZING ACTIVITY; URINE LEVEL;

EID: 0036264489     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (92)

1. Melatonin: Effects on brain function
2. On the effects of melatonin on sleep and behavior in man
3. Sleep induction by intranasal administration of melatonin
4. Effects of melatonin on human mood and performance
5. The use of melatonin in Alzheimer's disease
6. Bioavailability of oral melatonin in humans
7. Basic aspects of melatonin action
8. Binding of melatonin to human and rat plasma proteins
9. Measurement of 6-hydroxymelatonin in human urine and its diurnal variations
10. Cyclic 3-hydroxymelatonin: A melatonin metabolite generated as a result of hydroxyl radical scavenging
11. Sleep-inducing effects of low doses of melatonin ingested in the evening
12. Effects of low oral doses of melatonin, given 2-4 hours before habitual bedtime, on sleep in normal young humans
13. The effect of melatonin on normal sleep
14. Effect of melatonin on sleep and rectal temperature of young healthy evening types
15. Sleep laboratory investigations on hypnotic properties of melatonin
16. Melatonin improves evening napping
17. Effects of exogenous melatonin on memory, sleepiness, and performance after a 4-hr nap
18. Daytime melatonin administration: Effects on core temperature and sleep onset latency
19. Melatonin effect on daytime sleep in men: Suppression of EEG low frequency activity and enhancement of spindle frequency activity
20. Effect of inducing nocturnal serum melatonin concentrations in daytime on sleep, mood, body temperature, and performance
21. Daytime melatonin administration enhances sleepiness and theta/alpha activity in the waking EEG
22. Early morning melatonin administration impairs psychomotor vigilance
23. Effects of low doses of melatonin on late afternoon napping and mood
24. Hypnotic action of melatonin during daytime administration and its comparison with triazolam
25. Daytime melatonin and temazepam in young adult humans: Equivalent effects on sleep latency and body temperatures
26. Hypnotic activity of melatonin
27. Melatonin as an anxiolytic in rats: Time-dependence and interaction with the central gabaergic system
28. Melatonin: Role in gating nocturnal rise in sleep propensity
29. Melatonin binding sites in brain: Single or multiple?
30. Regional concentrations of melatonin in the rat brain in the light and dark period
31. Hypothyroidism and rehabilitation of day and night melatonin levels in pineal, hypothalamus and serum of male rats
32. High melatonin concentrations in third ventricular cerebrospinal fluid are not due to Galen vein blood recirculating through the choroid plexus
33. Melatonin administration in insomnia
34. Melatonin and insomnia
35. The role of melatonin and circadian phase in age-related sleep-maintenance insomnia: Assessment in a clinical trial of melatonin replacement
36. Polysomnographic study of the effect of melatonin on sleep in elderly patients with chronic primary insomnia
37. Improvement of sleep quality in elderly people by controlled-release melatonin
38. Effects of melatonin in elderly patients with sleep disturbance. A pilot study
39. Potential of melatonin replacement therapy in older patients with sleep disorders
40. The effects of exogenous melatonin on the total sleep time and daytime alertness of chronic insomniacs: A preliminary study
41. Improvement of sleep quality by melatonin
42. Melatonin in medically ill patients with insomnia: A double-blind, placebo-controlled study
43. Lack of changes in serum prolactin, FSH, TSH, and estradiol after melatonin treatment in doses that improve sleep and reduce benzodiazepine consumption in sleep-disturbed, middle-aged, and elderly patients
44. Effects of exogenous melatonin on pituitary hormones in humans
45. Randomized, double-blind clinical trial, controlled with placebo, of the toxicology of chronic melatonin treatment
46. Chronopharmacology of melatonin: Inhibition by benzodiazepine antagonism
47. Melatonin effects on behavior: Possible mediation by the central GABAergic system
48. Facilitation of benzodiazepine discontinuation by melatonin: A new clinical approach
49. Melatonin in older people with age-related sleep maintenance problems: A comparison with age matched normal sleepers
50. Diminished melatonin secretion in the elderly caused by insufficient environmental illumination
51. Decreased melatonin levels in postmortem cerebrospinal fluid in relation to aging, Alzheimer's disease, and apolipoprotein E-epsilon4/4 genotype
52. Sleep disturbances in community-dwelling patients with Alzheimer's disease
53. Treatment of sleep disturbance in Alzheimer's disease
54. Sleep disturbances in patients with mild-stage Alzheimer's disease
55. Monozygotic twins with Alzheimer's disease treated with melatonin: Case report
56. Effect of melatonin in selected populations of sleep-disturbed patients
57. Melatonin for treatment of sundowning in elderly persons with demen
58. Supplementary administration of artificial bright light and melatonin as potent treatment for disorganized circadian rest-activity and dysfunctional autonomic and neuroendocrine systems in institutionalized demented elderly persons
59. Exogenous melatonin in periodic limb movement disorder: An open clinical trial and a hypothesis
60. Melatonin as a therapy in REM sleep behavior disorder patients: An open-labeled pilot study on the possible influence of melatonin on REM-sleep regulation
61. Melatonin therapy for REM sleep behavior disorder
62. Melatonin administration can entrain the free-running circadian system of blind subjects
63. Melatonin treatment for circadian rhythm sleep disorders
64. Effects of melatonin on the quality of life in patients with delayed sleep phase syndrome
65. A single dose of melatonin prevents the phase delay associated with a delayed weekend sleep pattern
66. Use of slow-release melatonin in treatment-resistant depression
67. Melatonin add-on in manic patients with treatment resistant insomnia
68. The effect of melatonin in patients with fibromyalgia: A pilot study
69. Effect of melatonin on sleep quality of COPD intensive care patients: A pilot study
70. Low urinary 6-sulphatoxymelatonin levels in patients with coronary artery disease
71. Melatonin for chronic sleep onset insomnia in children: A randomized placebo-controlled trial
72. Melatonin as a sleep inductor for electro-encephalogram recordings in children
73. Melatonin replacement therapy in a child with a pineal tumor
74. Effects of a low dose of melatonin on sleep in children with Angelman syndrome
75. Clinical trials of controlled-release melatonin in children with sleep-wake cycle disorders
76. Melatonin improves sleep-wake patterns in psychomotor retarded children
77. Effect of melatonin on sleep-wake rhythm: The sleep diary of an autistic male
78. Jet lag: Clinical features, validation of a new syndrome-specific scale, and lack of response to melatonin in a randomized, double-blind trial
79. Effect of melatonin on jet lag after long haul flights
80. Standard melatonin intake and circadian rhythms of elite athletes after a transmeridian flight
81. Melatonin and jet lag: Confirmatory result using a simplified protocol
82. Melatonin and jet lag: Treatment schedule
83. Efficacy of melatonin treatment in jet lag, shift work, and blindness
84. Commentary: Evidence for melatonin as a circadian phase-shifting agent
85. Jet-lag and shift work: (2). Therapeutic use of melatonin
86. Use of melatonin in the treatment of phase shift and sleep disorders
87. Melatonin and jet-lag
88. Use of melatonin in recovery from jet-lag following an eastward flight across 10 time-zones
89. Effect of 3 mg melatonin on jet lag syndrome in an 8-h eastward flight
90. Melatonin for preventing and treating jet lag
91. A multifactorial approach employing melatonin to accelerate resynchronization of sleep-wake cycle after a 12 time-zone westerly transmeridian flight in elite soccer athletes
92. Bright light induction of strong (type 0) resetting of the human circadian pacemaker